ISSN - 0973-0958
https://www.pediatriconcall.com/Journal/images/journal_cover.jpg
   
 
Elevated serum bile acids in a child with liver disease
Elevated serum bile acids in a child with liver disease 28/05/2015 https://www.pediatriconcall.com/Journal/images/journal_cover.jpg
Dr Ira Shah.
Medical Sciences Department, Pediatric Oncall, Mumbai, India.

Cite this article  Copy Citation
Shah I. Elevated serum bile acids in a child with liver disease. Pediatr Oncall J. 2015;12: 119. doi: 10.7199/ped.oncall.2015.57

Address for Correspondence
Dr Ira Shah, 1, B Saguna, 271, B St Francis Road, Vile Parle {W}, Mumbai 400056

Clinical Problem :
A 2½ years old girl presented with generalized itching since 8 months of age. There was no history of jaundice. Her milestones were appropriate for age. On examination, weight was 9.4 kg, height was 81 cms, and she had dry excoriated skin with 9 cms hepatomegaly. Other systems were normal. Investigations showed bilirubin 1.6 mg, dl, SGOT - 41 IU, L, SGPT – 62 IU, L, GGTP – 20, total proteins 6.7 gm, dl, albumin 3.2 gm, dl, alkaline phosphatase 894 IU, L, prothrombin time 11.1 sec., partial thromboplastin time 31.7 sec, cholesterol = 190 mg, dl and serum bile acids of 152.4 µmol, L {Normal = 0 - 10 µmol, L}. Ultrasound abdomen showed mild hepatosplenomegaly with gall bladder sludge. Liver biopsy showed piecemeal necrosis with early cirrhosis and no bile stasis or bile duct proliferation. She was started on cholestyramine, diphenhydaramine, ursodeoxycholic acid to which she had mild relief.
 
Question :
How to interpret serum bile acids_?
 
Expert Opinion :
Bile acids are the main by-product of cholesterol metabolism in the liver and play a major role in maintaining bile flow. Many enzymes are involved in the conversion of cholesterol into bile acids. {1} Diseases associated with inborn error of bile acid metabolism lead to formation of atypical bile acids that may be toxic and cause decrease in bile flow or cholestasis whereas those with defects in bile acid transporters such as the progressive familial intrahepatic cholestasis {PFIC} may interfere with the transport processes of bile components. {1} Thus in patients with bile acid synthesis defect, the serum or urine primary bile acids will be normal whereas in patients with PFIC and other causes of neonatal cholestasis, it will be elevated. However, in these patients, there should be conjugated hyperbilirubinemia. In familial hypercholanemia, there is elevated serum bile acid concentrations, itching, and fat malabsorption and biochemical markers of liver injury are normal. {2} Thus in this child, with minimally elevated serum bilirubin, normal GGTP, itching, liver disease on histology, the elevated serum bile acids would suggest transport defect such as PFIC and not a bile acid synthetic defect.
 
Funding:  None  
 
Conflict of Interest: None

References :
  1. Yousef IM, Perwaiz S, Lamireau T, Tuchweber B. Urinary bile acid profile in children with inborn errors of bile acid metabolism and chronic cholestasis'screening technique using electrospray tandem mass-spectrometry (ES, MS, MS). Med Sci Monit. 2003; 9: MT21-31
  2. Hypercholanemia, Familial FHCA. Available at website: http://www.omim.org/entry/607748. Accessed on 25th May 2015
 
DOI No. :  https://doi.org/10.7199/ped.oncall.2015.57
 
Cite this article as :
Shah I. Elevated serum bile acids in a child with liver disease. Pediatr Oncall J. 2015;12: 119. doi: 10.7199/ped.oncall.2015.57
ask a doctor
Ask a Doctor
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0